Boston Scientific (BSX) Short-Term Debt issuances (2017 - 2026)

Boston Scientific has reported Short-Term Debt issuances for 9 years, with the latest figure at $1.4 billion in Q2 2026.

• Short-Term Debt issuances for Q2 2026 came in at $1.4 billion, up 183.2% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.7 billion (up 6.57% YoY), and the FY2025 annual result was $1.6 billion, up 216.47% from the prior year.
• Short-Term Debt issuances rose to $1.4 billion in Q2 2026, from $259.0 million in the prior quarter.
• Over five years, Short-Term Debt issuances peaked at $1.4 billion in Q2 2026 and troughed at -$41.0 million in Q3 2023.
• A 5-year average of $446.7 million and a median of $259.0 million in 2026 frame the typical range for Short-Term Debt issuances.
• The largest YoY upside for Short-Term Debt issuances was 183.2% in 2026 against a maximum downside of 76.08% in 2026.
• A 5-year view of Short-Term Debt issuances shows it stood at $250.0 million in 2022, then sank by 116.4% to -$41.0 million in 2023, then surged by 1329.27% to $504.0 million in 2024, then slumped by 97.62% to $12.0 million in 2025, then soared by 11700.0% to $1.4 billion in 2026.
• Per Business Quant data, the three most recent Short-Term Debt issuances figures were $1.4 billion in Q2 2026, $259.0 million in Q1 2026, and $12.0 million in Q3 2025.